Table of Content

1. Introduction



2. Research & Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Europe Biopsy Device Market



6. Market Share
6.1 By Products
6.2 By Imaging Technology
6.3 By County
6.4 By End User


7. Product
7.1 Needle Based Biopsy Devices
7.2 Biopsy Forceps
7.3 Localization Wire
7.4 Others Products


8. Imaging Technology
8.1 CT Scan
8.2 Stereotactic Guided
8.3 Ultrasound Guided
8.4 Mri Guided
8.5 Others


9. Country
9.1 United Kingdom
9.2 France
9.3 Germany
9.4 Italy
9.5 Spain
9.6 Russia
9.7 Rest of Europe


10. End User
10.1 Hospital and Clinics
10.2 Diagnostics Laboratories
10.3 Other


11. Porter’s Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Competition
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threats


13. Key Players Analysis
13.1 Becton, Dickinson and Company
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue

13.2 Thermo Fisher Scientific Inc.
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue

13.3 Bio-Rad Laboratories
13.3.1 Overview
13.3.2 Recent Developments
13.3.3 Revenue

13.4 Exact Sciences (Genomic Health)
13.4.1 Overview
13.4.2 Recent Developments
13.4.3 Revenue

13.5 Biocept
13.5.1 Overview
13.5.2 Recent Developments
13.5.3 Revenue

13.6 Roche Diagnostics
13.6.1 Overview
13.6.2 Recent Developments
13.6.3 Revenue

13.7 Myriad Genetics Inc.
13.7.1 Overview
13.7.2 Recent Developments
13.7.3 Revenue

13.8 Qiagen
13.8.1 Overview
13.8.2 Recent Developments
13.8.3 Revenue

13.9 NeoGenomics Laboratories
13.9.1 Overview
13.9.2 Recent Developments
13.9.3 Revenue

13.10 Quest Diagnostics Inc.
13.10.1 Overview
13.10.2 Recent Developments
13.10.3 Revenue



List of Figures

0

List of Tables

0